The Claim
In orbital fibroblasts from patients with severe Graves' ophthalmopathy, Graves' disease immunoglobulins induce hyaluronan synthesis more frequently than recombinant human TSH, despite recombinant human TSH producing stronger activation of cyclic AMP signaling.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In cells from the eyes of people with severe Graves' ophthalmopathy, antibodies from the disease trigger more hyaluronan production than a hormone called TSH, even though TSH activates a key signaling pathway more strongly.
See the scientific wording
In orbital fibroblasts from patients with severe Graves' ophthalmopathy, hyaluronan synthesis is more frequently induced by Graves' disease immunoglobulins than by recombinant human TSH, despite the latter's stronger activation of cyclic AMP signaling, indicating that the pathological process in Graves' ophthalmopathy is not a simple consequence of thyroid hormone receptor overstimulation.
Antibodies from patients with Graves' disease bind to a specific receptor on eye tissue cells, triggering a chemical signal that turns on a gene responsible for making a swelling-causing substance, even though a stronger signal from a different trigger does not produce the same effect.
What the research says
1 studyIn people with severe Graves' eye disease, immune antibodies cause eye swelling more than the body's own thyroid hormone, even though the hormone turns on a key cellular signal more strongly. This means the swelling isn't just from too much thyroid hormone — it's mainly caused by the immune system going haywire.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.